Sartorius | SRT3 - Pre Tax Profit


Sartorius reported EUR157.8M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -93M 135M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Moderna USD -799M 612M Dec/2025
Organon & Co USD -148M 391M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Sartorius EUR 157.8M 76.1M Mar/2026
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -343M 335.1M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025